Combination antiretroviral therapy failure and HIV super-infection

AIDS

Volumn 22, Issue 2, 2008, Pages 309-311

  Bezemer, Daniela ^a   Van Sighem, Ard ^a   De Wolf, Frank ^a,b   Cornelissen, Marion ^a   Van Der Kuyl, Antoinette C ^a   Jurriaans, Suzanne ^a   Van Der Hoek, Lia ^a   Prins, Maria ^a,c   Coutinho, Roel A ^c,d   Lukashov, Vladimir V ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Amsterdam Health Service   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; PRIORITY JOURNAL; STRUCTURAL GENE; VIRUS TRANSMISSION;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; EVOLUTION, MOLECULAR; FEMALE; GENES, POL; HIV INFECTIONS; HIV-1; HUMANS; MALE; NETHERLANDS; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; SEQUENCE ANALYSIS; SUPERINFECTION; TREATMENT FAILURE;

EID: 37549046380     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282f37489     Document Type: Article

References (22)

1. de Ronde A, van Dooren M, van der Hoek L, Bouwhuis D, de Rooij E, van Gemen B, et al. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus. J Virol 2001; 75:595-602.
2. Lukashov VV, de Ronde A, de Jong JJ, Goudsmit J. Epidemiology of HIV-1 and emerging problems. Int J Antimicrob Agents 2000; 16:463-466.
3. Vella S, Palmisano L. The global status of resistance to antiretroviral drugs. Clin Infect Dis 2005; 41 (Suppl 4):S239-S246.
4. Bezemer D, Jurriaans S, Prins M, van der Hoek L, Prins JM, de Wolf F, et al. Declining trend in transmission of drug-resistant HIV-1 in Amsterdam. AIDS 2004; 18:1571-1577.
5. van der Kuyl AC, Kozaczynska K, van den Burg R, Zorgdrager F, Back N, Jurriaans S, et al. Triple HIV-1 infection. N Engl J Med 2005; 352:2557-2559.
6. Cornelissen M, Jurriaans S, Kozaczynska K, Prins JM, Hamidjaja RA, Zorgdrager F, et al. Routine HIV-1 genotyping as a tool to identify dual infections. AIDS 2007; 21:807-811.
7. Allen TM, Altfeld M. HIV-1 superinfection. J Allergy Clin Immunol 2003; 112:829-835.
8. Pernas M, Casado C, Fuentes R, Perez-Elias MJ, Lopez-Galindez C. A dual superinfection and recombination within HIV-1 subtype B 12 years after primoinfection. J Acquir Immune Defic Syndr 2006; 42:12-18.
9. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, et al. HIV drug resistance acquired through superinfection. AIDS 2005; 19:1251-1256.
10. Brenner B, Routy J, Quan YD, Moisi D, Oliveira M, Turner D, et al. Persistence of mutidrug-resistant HIV-1 in primary infection leading to superinfection. AIDS 2004; 18:1653-1660.
11. Diaz RS, Pardini R, Catroxo M, Operskalski EA, Mosley JW, Busch MP. HIV-1 superinfection is not a common event. J Clin Virol 2005; 33:328-330.
12. Gonzales MJ, Delwart E, Rhee SY, Tsui R, Zolopa AR, Taylor J, et al. Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person-years of observation. J Infect Dis 2003; 188:397-405.
13. Fultz PN. HIV-1 superinfections: omens for vaccine efficacy? AIDS 2004; 18:115-119.
14. Truong HHM, Kellogg T, Klausner JD, Katz MH, Dilley J, Knapper K, et al. Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? Sex Transm Infect 2006; 82:461-466.
15. Stolte IG, Dukers NHTM, Geskus RB, Coutinho RA, De Wit JBR. Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS 2004; 18:303-309.
16. Stolte IG, Dukers NH, de Wit JB, Fennema JS, Coutinho RA. Increase in sexually transmitted infections among homosexual men in Amsterdam in relation to HAART. Sex Transm Infect 2001; 77:184-186.
17. Cox J, Beauchemin J, Allard R. HIV status of sexual partners is more important than antiretroviral treatment related perceptions for risk taking by HIV positive MSM in Montreal, Canada. Sex Transm Infect 2004; 80:518-523.
18. Elford J. Changing patterns of sexual behaviour in the era of highly active antiretroviral therapy. Curr Opin Infect Dis 2006; 19:26-32.
19. Stolte IG, De Wit JBF, van Eeden A, Coutinho RA, Dukers NHTM. Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behaviour among HIV infected homosexual men. AIDS 2004; 18:1943-1949.
20. van der Bij AK, Kolader ME, de Vries HJ, Prins M, Coutinho RA, Dukers NH. Condom use rather than serosorting explains differences in HIV incidence among men who have sex with men. J Acquir Immune Defic Syndr 2007; 45:574-580.
21. van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC, et al. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS 2003; 17:2227-2236.
22. Johnson VA, Brun-Vezinet F, Clotet B, Kuritzkes DR, Pillay D, Schapiro JM, et al. Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med 2006; 14:125-130.